SRPT FY 2022 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$933M+32.9% YoY

Gross Profit

$793M85.0% margin

Operating Income

-$536M-57.5% margin

Net Income

-$703M-75.4% margin

EPS (Diluted)

$-8.03

Cash Flow

Operating Cash Flow

-$325M

Free Cash Flow

-$358M

Stock-Based Comp.

$233M

Balance Sheet

Total Assets

$3.1B

Total Liabilities

$2.7B

Stockholders' Equity

$385M

Cash & Equivalents

$967M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$933M	$702M	+32.9%
Gross Profit	$793M	$605M	+31.1%
Operating Income	-$536M	-$460M	-16.6%
Net Income	-$703M	-$419M	-68.0%